Total Payments
$3,905
2024 Payments
$1,996
Companies
19
Transactions
192
Medicare Patients
61
Medicare Billing
$856.85
Payment Breakdown by Category
Food & Beverage$3,905 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,905 | 192 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $943.40 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $733.38 | 31 | $0 (2024) |
| PFIZER INC. | $412.37 | 24 | $0 (2024) |
| GlaxoSmithKline, LLC. | $289.64 | 17 | $0 (2024) |
| Lilly USA, LLC | $274.58 | 11 | $0 (2024) |
| Novo Nordisk Inc | $199.16 | 13 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $165.93 | 8 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $162.08 | 4 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $153.06 | 9 | $0 (2024) |
| Amgen Inc. | $144.38 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,996 | 106 | ABBVIE INC. ($389.44) |
| 2023 | $1,536 | 71 | ABBVIE INC. ($324.62) |
| 2022 | $372.97 | 15 | ABBVIE INC. ($229.34) |
All Payment Transactions
192 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $29.75 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.33 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/05/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: Oncology | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: PSYCHIATRY | ||||||
| 10/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Neuroscience | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 43 | 44 | $2,563 | $565.96 |
| 2022 | 1 | 18 | 19 | $1,178 | $290.89 |
Total Patients
61
Total Services
63
Medicare Billing
$856.85
Procedure Codes
3
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 71046 | X-ray of chest, 2 views | Office | 2023 | 32 | 33 | $2,046 | $385.06 | 18.8% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 11 | 11 | $517.00 | $180.90 | 35.0% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 18 | 19 | $1,178 | $290.89 | 24.7% |
About Melissa Gingerich
Melissa Gingerich is a Primary Care healthcare provider based in Claremore, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2022. The National Provider Identifier (NPI) number assigned to this provider is 1073262903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Melissa Gingerich has received a total of $3,905 in payments from pharmaceutical and medical device companies, with $1,996 received in 2024. These payments were reported across 192 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,905).
As a Medicare-enrolled provider, Gingerich has provided services to 61 Medicare beneficiaries, totaling 63 services with total Medicare billing of $856.85. Data is available for 2 years (2022–2023), covering 3 distinct procedure/service records.
Ad
Practice Information
- Specialty Primary Care
- Location Claremore, OK
- Active Since 03/18/2022
- Last Updated 03/18/2022
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1073262903
Products in Payments
- FARXIGA (Drug) $466.47
- VRAYLAR (Drug) $314.38
- QULIPTA (Drug) $310.15
- UBRELVY (Drug) $294.07
- ELIQUIS (Drug) $250.79
- AIRSUPRA (Drug) $236.91
- TRELEGY ELLIPTA (Drug) $236.31
- MOUNJARO (Drug) $211.08
- REXULTI (Drug) $185.26
- SPRAVATO (Drug) $162.08
- TRINTELLIX (Drug) $153.06
- PREVNAR 20 (Biological) $113.36
- Otezla (Drug) $103.25
- Cologuard Collection Kit (Device) $82.78
- XIFAXAN (Drug) $82.69
- JARDIANCE (Drug) $78.43
- Veozah (Drug) $77.52
- Kerendia (Drug) $66.45
- AREXVY (Drug) $53.33
- EVENITY (Biological) $41.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.